BACKGROUND: Spondyloepiphyseal dysplasia (SED) is rare genetic condition which leads to skeletal and joint deformities that can predispose patients to degenerative joint disease. There are limited reports on the results of total hip arthroplasty (THA) in this patient population. The purpose of this study is to review clinical and radiographic outcomes of THA performed in patients with SED at one institution. METHODS: Among 43,917 patients undergoing primary THA from 1970 to 2015, we identified 50 THAs performed in 29 patients with SED; 21 patients underwent bilateral THA (none simultaneous). There were 16 females and 13 males; mean age, body mass index, and height were 39 years, 28.7 kg/m2, and 145 cm, respectively. All patients were able to ambulate prior to the THA. Mean follow-up was 11 years (range 2-38). RESULTS: Mean implant survival for primary THA in SED patients at the 5, 10, and 20-year time points was 96%, 85%, and 55%, respectively. Thirteen patients required revision THA, most commonly for polyethylene wear (n = 6) and aseptic loosening (n = 5), and 4 additional patients underwent nonrevision reoperations. Prior to surgery, 90% of patients had severe or moderate pain, which was reduced to 8% of patients postoperatively (P < .001). Mean Harris Hip Score improved from 47 to 87 (P < .001). Prior to surgery, 64% of patients required gait aids, which reduced to 34% postoperatively (P < .001). CONCLUSION: THA provided significant pain reduction and improvement in function, with a majority of patients ambulating independently following the procedure. There was a high incidence of complications following THA in patients with SED, most commonly secondary to polyethylene wear and osteolysis from conventional polyethylene and historical implants. LEVEL OF EVIDENCE: Level IV, Therapy.
BACKGROUND:Spondyloepiphyseal dysplasia (SED) is rare genetic condition which leads to skeletal and joint deformities that can predispose patients to degenerative joint disease. There are limited reports on the results of total hip arthroplasty (THA) in this patient population. The purpose of this study is to review clinical and radiographic outcomes of THA performed in patients with SED at one institution. METHODS: Among 43,917 patients undergoing primary THA from 1970 to 2015, we identified 50 THAs performed in 29 patients with SED; 21 patients underwent bilateral THA (none simultaneous). There were 16 females and 13 males; mean age, body mass index, and height were 39 years, 28.7 kg/m2, and 145 cm, respectively. All patients were able to ambulate prior to the THA. Mean follow-up was 11 years (range 2-38). RESULTS: Mean implant survival for primary THA in SEDpatients at the 5, 10, and 20-year time points was 96%, 85%, and 55%, respectively. Thirteen patients required revision THA, most commonly for polyethylene wear (n = 6) and aseptic loosening (n = 5), and 4 additional patients underwent nonrevision reoperations. Prior to surgery, 90% of patients had severe or moderate pain, which was reduced to 8% of patients postoperatively (P < .001). Mean Harris Hip Score improved from 47 to 87 (P < .001). Prior to surgery, 64% of patients required gait aids, which reduced to 34% postoperatively (P < .001). CONCLUSION: THA provided significant pain reduction and improvement in function, with a majority of patients ambulating independently following the procedure. There was a high incidence of complications following THA in patients with SED, most commonly secondary to polyethylene wear and osteolysis from conventional polyethylene and historical implants. LEVEL OF EVIDENCE: Level IV, Therapy.
Authors: Siôn Glyn-Jones; Geraint E R Thomas; Patrick Garfjeld-Roberts; Roger Gundle; Adrian Taylor; Peter McLardy-Smith; David W Murray Journal: Clin Orthop Relat Res Date: 2015-02 Impact factor: 4.176
Authors: Ronuk M Modi; Michael M Kheir; Timothy L Tan; Gregory S Penny; Chi-Lung Chen; Hongyi Shao; Antonia F Chen Journal: Hip Int Date: 2017-05-10 Impact factor: 2.135
Authors: Paulien A Terhal; Rutger Jan A J Nievelstein; Eva J J Verver; Vedat Topsakal; Paula van Dommelen; Kristien Hoornaert; Martine Le Merrer; Andreas Zankl; Marleen E H Simon; Sarah F Smithson; Carlo Marcelis; Bronwyn Kerr; Jill Clayton-Smith; Esther Kinning; Sahar Mansour; Frances Elmslie; Linda Goodwin; Annemarie H van der Hout; Hermine E Veenstra-Knol; Johanna C Herkert; Allan M Lund; Raoul C M Hennekam; André Mégarbané; Melissa M Lees; Louise C Wilson; Alison Male; Jane Hurst; Yasemin Alanay; Göran Annerén; Regina C Betz; Ernie M H F Bongers; Valerie Cormier-Daire; Anne Dieux; Albert David; Mariet W Elting; Jenneke van den Ende; Andrew Green; Johanna M van Hagen; Niels Thomas Hertel; Muriel Holder-Espinasse; Nicolette den Hollander; Tessa Homfray; Hanne D Hove; Susan Price; Annick Raas-Rothschild; Marianne Rohrbach; Barbara Schroeter; Mohnish Suri; Elizabeth M Thompson; Edward S Tobias; Annick Toutain; Maaike Vreeburg; Emma Wakeling; Nine V Knoers; Paul Coucke; Geert R Mortier Journal: Am J Med Genet A Date: 2015-01-21 Impact factor: 2.802
Authors: Matthew G Teeter; Xunhua Yuan; Lyndsay E Somerville; Steven J MacDonald; Richard W McCalden; Douglas D Naudie Journal: Can J Surg Date: 2017-06 Impact factor: 2.089
Authors: Richard N de Steiger; Orhun Muratoglu; Michelle Lorimer; Alana R Cuthbert; Stephen E Graves Journal: Acta Orthop Date: 2015-06-28 Impact factor: 3.717